Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 29, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 03, 2026
Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways.
Journal: bioRxiv : the preprint server for biology
Published: January 23, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 17, 2025
Reno-Duodenal Fistula Caused by Metastatic Lung Cancer.
Journal: Journal of Brown hospital medicine
Published: April 14, 2025
Consideration of Pneumonectomy in the Era of Chemo-Immunotherapy in Resectable NSCLC.
Journal: The Thoracic and cardiovascular surgeon reports
Published: January 24, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 28, 2024
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.
Journal: Clinical and translational medicine
Published: July 27, 2023
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers.
Journal: Molecular cancer therapeutics
Published: April 25, 2023
Last Updated: 09/26/2026